Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$39,928.00
Mar 1, 2018
Building Capacity for Patient Engagement and Patient-Oriented Research in Clinical Trials
$455,175.00
Apr 1, 2018
MicroRNAs in pregnancy and gestational diabetes: origin and functions for clinical applications
$1,000.00
Apr 1, 2018
Validating the Pictorial Fit-Frail Scale (PFFS) in a Memory Clinic Setting
$1,000.00
Apr 1, 2018
Determining the Minimal Clinically Important Difference: MRI Ventilation Defect Percent in Asthmatics
$140,000.00
Apr 1, 2018
Integrating person-centered and precision psychiatry in the clinical assessment of depression
$52,500.00
Apr 1, 2018
Identifying Clinical, Demographic, & Genomic Risk Factors for Treatment-Resistant Psychiatric Disorders
$3,010,120.00
Jul 1, 2018
Molecular and physiological understanding of the protein tyrosine phosphatome towards clinical applications.
$742,050.00
Oct 1, 2018
Functional and clinical characterization of PALMD calcific aortic valve stenosis risk locus
$929,475.00
Oct 1, 2018
Precision medicine in smoking cessation: nicotine metabolism genetics in nine clinical trials
$3,997,503.00
Apr 1, 2017
Development of a safe, effective and clinically acceptable VSV-based HIV vaccine